Unilife

Unilife Corporation developed, manufactured and supplied proprietary injectable drug delivery systems. Unilife’s focus was on developing single-use safety syringes and wearable injector platforms for the delivery of biologics. The company ceased operations in 2017.

Research & Production Facility
Unilife Corporation
250 Cross Farm Lane
York
PA 17406
United States

Phone / Contact

T: +1 717 384 3400
F: +1 717 384 3401

Articles by Unilife

PROVIDING PHARMACEUTICAL COMPANIES WITH MARKET-LEADING WEARABLE INJECTORS

Unilife highlights some of the key reasons its customer-centric strategy is helping it establish long-term, commercial relationships with many leading pharmaceutical companies and industry suppliers.

DELIVERING VALUE FOR INJECTABLES: UNMET NEEDS, DEVICE SOLUTIONS & THERAPEUTIC OUTCOMES

Unilife examines why pharmaceutical companies are leveraging innovative delivery systems to enhance and differentiate their injectable products so that they can generate powerful value-based.

SELECTING THE RIGHT WEARABLE INJECTOR TECHNOLOGY AND PARTNER

In this article, Alan Shortall provides a detailed run-down of how Unilife’s wearable devices portfolio meets the numerous requirements that pharma partners and patients demand of such a devices, and explains how this differentiates Unilife’s products from others in the space.

PREFILLED SYRINGES

PROVIDING FULL-SERVICE SOLUTIONS FOR INJECTABLE DRUG DELIVERY

Alan Shortall provides an introduction to some significant trends in the pharma industry, such as the use of smart phone apps and the move of injectable medication delivery away from the clinical setting.

CRITERIA FOR SELECTING A WEARABLE INJECTOR TECHNOLOGY AND PARTNER

Alan Shortall provides a detailed account of the significant opportunities that wearable injection devices present pharmaceutical and biotech companies.

Top